Thromb Haemost 1979; 42(01): 275
DOI: 10.1055/s-0039-1684842
Cross-Linked Fibrin Derivatives
Schattauer GmbH

Identification of Crosslinked Fibrin Degradation Products in Plasma of Patients During Fibrinolytic Therapy Using a Heat Extraction/SDS-Polyacrylamide Gradient Gel Electrophoretic Technique

C.W. Francis
1   Hematology Unit, Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York 14642, USA
,
V. J. Marder
1   Hematology Unit, Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York 14642, USA
,
S.E. Martin
1   Hematology Unit, Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York 14642, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
18. April 2019 (online)

Preview

To quantitate plasmic degradation products of crosslinked fibrin in plasma, a technique has been developed which employs heat precipitation, SDS-polyacrylamide gradient gel electrophoresis of the dissolved, reduced heat precipitate, and quantitation by densitometrie analysis of γ-γ derivatives identified in the stained get. When studied with this sensitive electrophoretic technique, plasmic digests of purified crosslinked fibrin were found to contain a heterogeneous group of γ-γ chain derivatives with molecular weights between 76,000 and 100,000 daltons. In samples of normal plasma to which digests of crosslinked fibrin had been added, this heat extraction/ge1 electrophoretic technigue allowed the detection of γ-γ derivatives with a sensitivity of 20 µg/ml. Derivatives of γ-γ chains with molecular weights of 82,000 and 86,000 daltons have been identified in the plasma of patients with DIC and during fibrinolytic therapy but were not found in normal plasma or in normal plasma treated in vitro with urokinase. This quantitative assay can be performed in 24 hours and appears to be of value in judging the efficacy of thrombolytic therapy.